PMGC Holdings (ELAB) Operating Leases (2022 - 2026)
PMGC Holdings' (ELAB) quarterly Operating Leases came in at $4.2 million in Q2 2026, up 141.18% quarter-over-quarter from $1.7 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) Operating Leases (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed Operating Leases across 5 years of filings, most recently posting $4.2 million for Q2 2026.
- In Q2 2026, Operating Leases changed N/A year-over-year to $4.2 million; the TTM figure through Jun 2026 stood at $4.2 million (changed N/A YoY), while the FY2025 annual figure was $972843.0, changed N/A from the prior year.
- Operating Leases came in at $4.2 million for Q2 2026 at PMGC Holdings, up from $1.7 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $103.3 million in Q3 2023 to a low of $26571.0 in Q1 2024.
- Average Operating Leases over 5 years is $13.9 million, with a median of $979257.0 recorded in 2025.
- The largest YoY upside for Operating Leases was 62.06% in 2023 against a maximum downside of 62.06% in 2023.
- Over 5 years, Operating Leases stood at $172601.0 in 2022, then slumped by 62.06% to $65489.0 in 2023, then tumbled by 59.43% to $26571.0 in 2024, then surged by 3561.3% to $972843.0 in 2025, then surged by 331.09% to $4.2 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $4.2 million in Q2 2026, $1.7 million in Q1 2026, and $972843.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.35 Bn | 192.36 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.02 Bn | 176.84 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.48 Bn | 123.63 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.98 Bn | 73.99 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.30 Bn | 55.12 Bn | 1.37 Bn |
| 6 | Moderna | 53.75 Bn | 48.61 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.99 Bn | 29.69 Bn | 992.69 Mn |
| 8 | Biogen | 31.95 Bn | 30.66 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn |
| 10 | PMGC Holdings | 2.27 Mn | -16.52 Mn | 385,691.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.19 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Dec 31, 2025 | 972,843.00 |
| Sep 30, 2025 | 985,671.00 |
| Mar 31, 2024 | 26,571.00 |
| Dec 31, 2023 | 65,489.00 |
| Sep 30, 2023 | 103.31 Mn |
| Dec 31, 2022 | 172,601.00 |